Related Experiment Video

Updated: Jun 14, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey

Charles De Smet1, Axelle Loriot1

  • 1Catholic University of Louvain.

Epigenetics
|March 23, 2010
PubMed

Insights

DNA hypomethylation, a key change in cancer, involves non-random methylation losses. Transcriptional regulators may influence these patterns during tumor development, suggesting transient DNA demethylation events.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genomics

Background:

  • Cytosine methylation is a crucial, heritable DNA modification impacting gene repression and genome stability in mammals.
  • While generally stable in adults, genomic methylation patterns are significantly altered in most human tumors.
  • Cancer cells exhibit both hypermethylated and, more extensively, hypomethylated DNA segments.

Purpose of the Study:

  • To review the current understanding of the mechanisms driving DNA hypomethylation in tumors.
  • To explore the non-random nature of methylation loss and proposed patterns of mosaic hypomethylation.
  • To discuss the potential role of transient DNA demethylation events and transcriptional regulators in establishing these patterns.

Main Methods:

  • Literature review of existing research on DNA methylation and cancer.
  • Analysis of evidence suggesting mechanisms for DNA hypomethylation in tumor development.
  • Discussion of proposed models involving transient demethylation and transcriptional regulation.

Main Results:

  • DNA hypomethylation in tumors is extensive and appears to follow non-random, mosaic patterns.
  • Evidence suggests these patterns arise from historical transient DNA demethylation events.
  • Transcriptional regulators are implicated in determining regions that escape remethylation.

Conclusions:

  • DNA hypomethylation in cancer is a complex process, not a random event.
  • Transient DNA demethylation followed by selective remethylation, influenced by transcriptional regulators, likely shapes tumor hypomethylation patterns.
  • Understanding these mechanisms may reveal critical stages in tumor development.

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Methylated DNA Immunoprecipitation21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...